It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds ...

Some long COVID patients who took an extended course of Paxlovid saw temporary or lasting improvement, according to a small new case series published in the journal Communications Medicine.

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last. By Pam Belluck Pam Belluck has ...

A new real-world study published in PLOS Medicine that looked at outcomes of 703,647 patients with COVID-19 seen at 34 US clinics in 2022 and 2023 found that Paxlovid use was correlated with lower ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

Nearly 3 in 4 people (72%) agree COVID is still a serious public health issue, including more than a third (35%) who strongly ...

In summary, the UCSF study suggests that extended courses of Paxlovid might help some individuals with long COVID, though results vary widely. While this approach is not a universal solution, it ...

“It’s very possible that within long COVID, there’s different disease types,” said Singh, now head of internal medicine at the University of Iowa. Maybe Paxlovid or other antivirals would ...